Centre for Genomics, Molecular and Human Genetics, Jiwaji University, Gwalior, 474011, India.
Key Laboratory of Medical Molecular Virology, Ministry of Eductation and Ministry of Health School of Basic Medicine, Fundan University, Shanghai, 200032, China.
J Infect Public Health. 2019 May-Jun;12(3):395-402. doi: 10.1016/j.jiph.2018.12.009. Epub 2019 Jan 2.
Sahariya, a primitive tribal group, residing in Gwalior and Sheopur districts of Madhya Pradesh, India, show high incidence and prevalence of pulmonary tuberculosis (PTB). The study was designed to understand the genetic diversity and phenotype - genotype association of drug resistant M. tuberculosis strains, infecting Sahariya tribe.
A total of 103 pulmonary tuberculosis patients from Sahariya tribe were recruited from Gwalior and Sheopur districts. Sputum samples were collected and cultured on LJ slants and drug sensitivity tests were carried out. Genomic DNA was extracted, followed by spoligotyping and genotyping of drug target genes, katG and rpoB, using MAS-PCR, PCR-RFLP and DNA sequencing.
Seventeen different spoligotypes were identified, in which, EAI3_IND/ST11 M. tuberculosis strain appeared predominant, followed by CAS1_Delhi/ST26. Results of our phenotypic drug susceptibility test identified high incidence (12.6%) of isoniazid-resistant tuberculosis, while 4.85% isolates were multi drug resistant (MDR). Further genotyping of drug target genes identified 8.7% of isoniazid-R isolates to have a mutation at katG codon 463, while 3.8% isolates showed mutations at two sites, katG codons 315 and 463. In case of MDR-TB isolates, all from CAS lineage, 3.85% had mutations on katG and rpoB genes, at codon 463 and codon 526, respectively, while 0.97% isolates were harbouring mutations at codons 315, 463 and 531.
Our findings have revealed that EAI3_IND strain is the predominant strain infecting Sahariya. The incidence of isoniazid-R M. tuberculosis strain infection is high, with an increased propensity to evolve into MDR-TB. Therefore, the TB centres should also consider isoniazid-R status of the isolates along with CBNAAT before deciding the drug regimen for the patients.
居住在印度中央邦瓜廖尔和谢普尔地区的撒哈里亚部落,其肺结核(PTB)发病率和患病率都很高。本研究旨在了解感染撒哈里亚部落的耐药结核分枝杆菌菌株的遗传多样性和表型-基因型相关性。
从瓜廖尔和谢普尔地区招募了 103 名撒哈里亚部落的肺结核患者。采集痰液样本并在 LJ 斜面上培养,进行药物敏感性试验。提取基因组 DNA,然后使用 MAS-PCR、PCR-RFLP 和 DNA 测序对 katG 和 rpoB 药物靶基因进行 spoligotyping 和基因分型。
共鉴定出 17 种不同的 spoligotype,其中 EAI3_IND/ST11 结核分枝杆菌菌株占主导地位,其次是 CAS1_Delhi/ST26。我们的表型药敏试验结果表明,异烟肼耐药结核病的发生率很高(12.6%),而 4.85%的分离株为耐多药(MDR)。进一步对药物靶基因进行基因分型,发现 8.7%的异烟肼耐药分离株 katG 密码子 463 发生突变,而 3.8%的分离株在 katG 密码子 315 和 463 处发生突变。MDR-TB 分离株均来自 CAS 谱系,其中 3.85%的分离株在 katG 和 rpoB 基因的密码子 463 和 526 处发生突变,而 0.97%的分离株在密码子 315、463 和 531 处发生突变。
我们的研究结果表明,EAI3_IND 菌株是感染撒哈里亚人的主要菌株。异烟肼耐药结核分枝杆菌菌株的感染率很高,并有向 MDR-TB 发展的倾向。因此,TB 中心在为患者制定药物治疗方案时,还应考虑分离株的异烟肼耐药情况和 CBNAAT。